Keyphrases
Abciximab
100%
Balloon Angioplasty
25%
Bleeding
25%
Bolus
25%
Carotid Artery Stenosis
50%
Carotid Restenosis
100%
Carotid Stenting
100%
Cerebral Ischemic Stroke
25%
Continuous Infusion
25%
Duplex Surveillance
25%
Embolic Event
25%
Glycoprotein IIb/IIIa Inhibitors
25%
Internal Carotid Artery
25%
Ischaemic Episode
25%
Ischemic Events
25%
Luminal Diameter
50%
Percutaneous Revascularization
25%
Peripheral Vascular
25%
Postsurgical
100%
Recurrent Stenosis
75%
Residual Stenosis
25%
Restenosis
25%
Revascularization
25%
Stent
25%
Stented Arteries
25%
Strecker
25%
Studying up
25%
Surveillance Studies
25%
Vascular Complications
25%
Wallstent
25%
Medicine and Dentistry
Abciximab
100%
Bleeding
25%
Carotid Artery Stenosis
50%
Carotid Artery Stenting
100%
Continuous Infusion
25%
Fibrinogen Receptor
25%
Internal Carotid Artery
50%
Percutaneous Transluminal Angioplasty
25%
Receptor Antagonist
25%
Restenosis
100%
Revascularization
25%
Stenosis
100%
Stenting
25%
Pharmacology, Toxicology and Pharmaceutical Science
Abciximab
100%
Bleeding
25%
Carotid Artery Obstruction
50%
Fibrinogen Receptor
25%
Receptor Antagonist
25%
Restenosis
100%
Stenosis
100%
Neuroscience
Abciximab
100%
Fibrinogen Receptor
16%
Internal Carotid Artery
33%
Receptor Antagonist
16%
Stenosis
100%